| |
| |
|
| Insider
Information: |
Piacquad David |
| Relationship: |
SVP, Business Developm... |
| City: |
Thousand Oaks |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
44,787 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$13,698,104 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
44,787 |
|
|
| Total
Value |
$13,698,104 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -2.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amgen Inc |
AMGN |
SVP, Business Developm... |
2021-05-03 |
44,787 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AMGN |
Amgen Inc |
SVP, Business Development |
• • – |
2018-05-11 |
4 |
OE |
$54.71 |
$820,650 |
D/D |
15,000 |
51,566 |
0 |
- |
|
| AMGN |
Amgen Inc |
SVP, Business Development |
• • – |
2018-05-11 |
4 |
D |
$170.77 |
$1,683,792 |
D/D |
(9,860) |
41,706 |
0 |
- |
|
| AMGN |
Amgen Inc |
SVP, Business Development |
• • – |
2015-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
9,459 |
36,321 |
0 |
- |
|
| AMGN |
Amgen Inc |
SVP, Business Development |
• • – |
2020-02-06 |
4 |
S |
$229.93 |
$2,130,079 |
D/D |
(9,264) |
39,700 |
0 |
% |
|
| AMGN |
Amgen Inc |
SVP, Business Development |
• • – |
2018-11-30 |
4 |
OE |
$54.69 |
$355,485 |
D/D |
6,500 |
45,128 |
0 |
- |
|
| AMGN |
Amgen Inc |
SVP, Business Development |
• • – |
2019-11-20 |
4 |
OE |
$156.35 |
$898,856 |
D/D |
5,749 |
53,361 |
0 |
- |
|
| AMGN |
Amgen Inc |
SVP, Business Development |
• • – |
2017-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
5,635 |
37,989 |
0 |
- |
|
| AMGN |
Amgen Inc |
SVP, Business Development |
• • – |
2016-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
5,305 |
34,212 |
0 |
- |
|
| AMGN |
Amgen Inc |
SVP, Business Development |
• • – |
2019-11-20 |
4 |
D |
$224.50 |
$1,093,315 |
D/D |
(4,870) |
48,491 |
0 |
- |
|
| AMGN |
Amgen Inc |
SVP, Business Development |
• • – |
2015-03-27 |
4 |
D |
$160.55 |
$706,741 |
D/D |
(4,402) |
32,036 |
0 |
- |
|
| AMGN |
Amgen Inc |
SVP, Business Development |
• • – |
2018-11-30 |
4 |
D |
$202.37 |
$831,538 |
D/D |
(4,109) |
41,019 |
0 |
- |
|
| AMGN |
Amgen Inc |
SVP, Business Development |
• • – |
2018-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
4,031 |
37,474 |
0 |
- |
|
| AMGN |
Amgen Inc |
SVP, Business Development |
• • – |
2020-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
3,711 |
43,411 |
0 |
- |
|
| AMGN |
Amgen Inc |
SVP, Business Development |
• • – |
2019-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
3,676 |
47,674 |
0 |
- |
|
| AMGN |
Amgen Inc |
SVP, Business Development |
• • – |
2019-12-13 |
4 |
OE |
$162.60 |
$467,475 |
D/D |
2,875 |
51,389 |
0 |
- |
|
| AMGN |
Amgen Inc |
SVP, Business Development |
• • – |
2017-04-26 |
4 |
D |
$164.70 |
$458,360 |
D/D |
(2,783) |
32,549 |
0 |
- |
|
| AMGN |
Amgen Inc |
SVP, Business Development |
• • – |
2015-04-26 |
4 |
D |
$167.91 |
$444,626 |
D/D |
(2,648) |
29,058 |
0 |
- |
|
| AMGN |
Amgen Inc |
SVP, Business Development |
• • – |
2021-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,648 |
45,504 |
0 |
- |
|
| AMGN |
Amgen Inc |
SVP, Business Development |
• • – |
2017-03-24 |
4 |
D |
$166.04 |
$419,749 |
D/D |
(2,528) |
35,547 |
0 |
- |
|
| AMGN |
Amgen Inc |
SVP, Business Development |
• • – |
2019-12-13 |
4 |
D |
$235.99 |
$572,276 |
D/D |
(2,425) |
48,964 |
0 |
- |
|
| AMGN |
Amgen Inc |
SVP, Business Development |
• • – |
2016-03-25 |
4 |
D |
$149.24 |
$344,297 |
D/D |
(2,307) |
31,999 |
0 |
- |
|
| AMGN |
Amgen Inc |
SVP, Business Development |
• • – |
2014-08-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,957) |
25,711 |
0 |
- |
|
| AMGN |
Amgen Inc |
SVP, Business Development |
• • – |
2019-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
1,691 |
47,555 |
0 |
- |
|
| AMGN |
Amgen Inc |
SVP, Business Development |
• • – |
2020-03-20 |
4 |
D |
$198.76 |
$316,227 |
D/D |
(1,591) |
41,879 |
0 |
- |
|
| AMGN |
Amgen Inc |
SVP, Business Development |
• • – |
2018-03-23 |
4 |
D |
$176.08 |
$267,466 |
D/D |
(1,519) |
36,004 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
